Showing 161 - 180 results of 99,472 for search '(( i ae decrease ) OR ( 5 ((((fold decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.50s Refine Results
  1. 161
  2. 162
  3. 163

    MMR mutants show decreased mating-type silencing. by Qian Liu (135614)

    Published 2020
    “…<i>sir1Δ</i> mutant was used as a positive control. <b>(D)</b> Cells of indicated strains were 10-fold serially diluted and then spotted onto SC (left), SD-Ura (middle) and SC+FOA(right) agar plates, the <i>sir1Δ</i> mutant served as a positive control. …”
  4. 164
  5. 165

    Solicited local AEs. by Zacchaeus Anywaine (3578855)

    Published 2022
    “…Percentages reflect <i>n</i>/<i>N</i> where <i>n</i> is the number of participants with one or more AEs and <i>N</i> is the number of participants with available reactogenicity data after the given dose (solicited AEs) or the number of participants who received the given dose (unsolicited AEs). …”
  6. 166
  7. 167
  8. 168
  9. 169

    TGFβ1 expression was increased, and RASAL1 expression was decreased in NTM cells in response to a hypoxic environment. by Fiona McDonnell (2636635)

    Published 2016
    “…</b> After 24 hours, RASAL1 was decreased; fold change 0.51+/-0.13 (P<0.05). <b>C.</b> Western blotting shows an apparent increase in TGFβ1 after 6 hours. …”
  10. 170
  11. 171
  12. 172

    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…</p>Results<p>In a dose-dependent manner, ruxolitinib addition synergizes with UCB-Tregs to suppress SLE-PBMC proliferation, inhibit CD8<sup>+</sup> T cells, and reduce phosphorylation of STAT3/STAT5/AKT in CD8<sup>+</sup> T cells. …”
  13. 173

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…</p>Results<p>In a dose-dependent manner, ruxolitinib addition synergizes with UCB-Tregs to suppress SLE-PBMC proliferation, inhibit CD8<sup>+</sup> T cells, and reduce phosphorylation of STAT3/STAT5/AKT in CD8<sup>+</sup> T cells. …”
  14. 174
  15. 175
  16. 176

    Triple stain for miR-200b, AE1/AE3, and laminin-5γ2 at the invasive front. by Kirsten Nguyen Knudsen (813125)

    Published 2017
    “…<b>(B-F)</b> Enlarged area from A. <b>(B)</b> Tumor budding cells co-expressing cytokeratin AE1/AE3 and laminin-5γ2 (red) appear yellow as indicated by white arrowheads. …”
  17. 177
  18. 178
  19. 179
  20. 180